Purchase Order 36C25623P0693
- Not listed
- This firm fixed-price purchase order for $77,700 was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for Afirma Gene Expression Classifier and Atlas Expression Classifier testing, which analyze gene expression patterns in thyroid biopsy samples to determine malignancy risk and aid in diagnosis and treatment decisions for veterans. This award is not set...
- This is a $512,000.00 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Veracyte, Inc., a for-profit medical diagnostics company. The contract, which is not set aside for any specific business category, is for the provision of specialized genomic testing services, primarily focused on cancer diagnostics, to the VA's Veterans Integrated Service Network (VISN) 17. Veracyte has been awarded numerous contracts by the VA and Department of Defense to...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostics company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16). The contract is for $405,018.00 and involves the provision of genomic testing services, specifically Veracyte's proprietary genomic testing products and services. This is a firm fixed-price purchase order contract with a period of performance ending on May 31, 2029. The contract is not set aside and appears to...
- The U.S. Department of Veterans Affairs (VA) awarded a $77,295.91 firm fixed price delivery order contract to Veracyte, Inc., a for-profit organization, to provide the AFIRMA Thyroid Genomic Classifier (GEC) test. This test analyzes gene expression patterns in thyroid biopsy samples to aid in diagnosis and treatment planning. The contract was issued without a set-aside and has a period of performance through November 4, 2022. Veracyte has also been awarded an Indefinite Delivery Indefinite...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order to Veracyte, Inc. on January 1, 2026, for thyroid molecular genomic testing services with a ceiling value of $1.85M and an ultimate completion date of July 31, 2028. This non-set-aside contract is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and will be performed in Temple, Texas. Veracyte, a South San Francisco-based medical diagnostic...
- This is a firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Veracyte, Inc., a for-profit medical diagnostic company based in South San Francisco, California. The contract is for $593,715.57 and provides specialty genomic laboratory testing services, primarily focused on cancer detection, diagnosis, and treatment planning through advanced gene expression analysis. The contract is awarded under the VA's Medical Laboratory Testing and Analysis Services...
- This is a $141,132.01 firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for cancer screening tests, with no set-aside designation. Veracyte has also been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle from VISN 23 to provide reference laboratory services, with a potential value of $600,000 through April 2028....
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostic company, by the Veterans Integrated Service Network (VISN) 23, a division of the U.S. Department of Veterans Affairs (VA). The contract is an Indefinite Delivery Vehicle (IDV) with a Delivery Order contract type and Firm Fixed Price pricing, with a ceiling value of $39,200.00. The contract is for Veracyte's reference laboratory services to support VISN 23, which covers VA medical facilities in multiple states....
- This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command to Veracyte, Inc., a for-profit organization that provides genomic testing services. The contract, valued at $96,176.63, is for the provision of supply/service in support of the agency's cancer detection and diagnosis efforts. Veracyte holds an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle with the Veterans Health Administration's Veterans Integrated Service Network 23, valued at up to...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostic company, by the Veterans Integrated Service Network 23 (VISN 23), a division of the Department of Veterans Affairs (VA). The contract is an Indefinite Delivery, Indefinite Quantity (IDIQ) with a ceiling value of $112,200.00 for reference laboratory services. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2026. The contract is not set aside and was awarded on May 1,...
This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services, to conduct referral laboratory testing for thyroid genomic expression classifier (GEC) testing. The $202,552.00 contract has a period of performance through September 30, 2024. Veracyte has provided similar genomic testing services to support cancer detection and diagnosis for the Department of Defense and VA medical facilities under past federal contracts. This award is not associated with a set-aside program. Veracyte also holds a $600,000 Indefinite Delivery Indefinite Quantity (IDIQ) contract with VISN 23 to provide specialized pathology testing to support VA hospitals and clinics in northern and central California.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | ($132k) | 11/9/24 | |
| P00003 | Exercise an Option | $0 | 4/20/24 | |
| P00002 | Funding Only Action | $2.3k | 4/13/24 | |
| P00001 | Supplemental Agreement for work within scope | $165.2k | 11/30/23 | |
| Not listed | Not listed | $33.2k | 4/18/23 |